Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MUSTARDD-PD
2009-015170-35Phase 3Terminated
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Parkinson's disease dementia (PDD) comparing Donepezil arm with Placebo arm (2 arms). Primary endpoints: Change in Mattis Dementia Rating Scale (DRS-2), Change in 10-item Neuropsychiatric Inventory (NPI-10) and 1 more. Started Dec 2011; status: terminated.
02
Drugs
donepezil
03
Conditions
Parkinson's disease dementia (PDD)
Beyond the preview
Go deeper on 2009-015170-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015170-35.